2001•PubMedRequires access

[Combination therapy of lung cancer with metastatic pleurisy].

Vladimir P. Kharchenko, G A Galil-Ogly, G A Pan'shin, I E Sergeev, A A Gvarishvili, Eltyshev Na, O A Vasil'ev, Evtikheev Ev

Open publisher page 0 citations

Abstract

The data on the surgical and combined treatment of 35 cases of lung cancer associated with pleural effusion detected during surgery have been evaluated. Mean 5-year survival was 68.5%, pleural effusion--70%.

About this research paper

What this paper is about

The data on the surgical and combined treatment of 35 cases of lung cancer associated with pleural effusion detected during surgery have been evaluated. Mean 5-year survival was 68.5%, pleural effusion--70%.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The data on the surgical and combined treatment of 35 cases of lung cancer associated with pleural effusion detected during surgery have been evaluated. Mean 5-year survival was 68.5%, pleural effusion--70%.

Key concepts: Medicine, Pleural effusion, Pleurisy, Lung cancer, Malignant pleural effusion, Effusion, Lung, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
[Combination therapy of lung cancer with metastatic pleurisy]. — Research Paper | ScholarLens